Investigating HPA Axis Function in Women Undergoing Chemotherapy with Adjunctive High-Dose Dexamethasone: A Prospective Pilot Study - Summary - MDSpire
Advertisement
Investigating HPA Axis Function in Women Undergoing Chemotherapy with Adjunctive High-Dose Dexamethasone: A Prospective Pilot Study
To evaluate longitudinal changes in morning cortisol and ACTH concentrations in breast cancer patients receiving dexamethasone as chemotherapy premedication, assessing potential suppression of the HPA axis.
Key Findings:
Morning cortisol and ACTH concentrations showed an overall downward tendency during treatment.
No statistically significant changes were observed in cortisol or ACTH concentrations.
The study did not demonstrate significant suppression of HPA axis function during intermittent high-dose dexamethasone administration.
Interpretation:
The findings suggest limitations of single cortisol measurements and emphasize the need for a longitudinal approach to assess adrenal function in oncology patients.
Limitations:
Small sample size of 47 participants.
Lack of dynamic testing to better evaluate HPA axis function.
Single time-point measurements may not accurately reflect adrenal function.
Conclusion:
Further studies incorporating dynamic testing are required to determine the optimal method for evaluating HPA axis function during intermittent glucocorticoid exposure.
by Elżbieta Turska, Krzysztof Lewandowski, Igor Symonowicz, Magdalena Kobus, Wojciech Horzelski, Tomasz Kubiatowski, Justyna Marchewka-Długońska, Ewa Kalinka
